Business Description
Prolight Diagnostics AB
ISIN : SE0003618230
Compare
Compare
Traded in other countries / regions
PRLD.Sweden0G5I.UK IPO Date
2017-03-31Description
Prolight Diagnostics AB is developing with technology partners near-patient test system based on the patented technology, for use in so-called Point of Care Testing (POCT). The company uses technology such as Mico ELISA and Flex membrane and PLD Micro Flex.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.78 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -157.1 | |||||
| 3-Year EPS without NRI Growth Rate | -35.2 | |||||
| 3-Year Book Growth Rate | -22.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 16.87 | |||||
| 9-Day RSI | 29.99 | |||||
| 14-Day RSI | 35.05 | |||||
| 6-1 Month Momentum % | -64.64 | |||||
| 12-1 Month Momentum % | -62.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.27 | |||||
| Quick Ratio | 2.27 | |||||
| Cash Ratio | 1.76 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -23.7 | |||||
| Shareholder Yield % | -52.9 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -82.91 | |||||
| ROA % | -56.27 | |||||
| ROIC % | -11.1 | |||||
| ROC (Joel Greenblatt) % | -4894.9 | |||||
| ROCE % | -58.73 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.47 | |||||
| Price-to-Tangible-Book | 5.85 | |||||
| EV-to-EBIT | -0.2 | |||||
| EV-to-EBITDA | -0.2 | |||||
| EV-to-FCF | -0.65 | |||||
| Price-to-Net-Current-Asset-Value | 11.7 | |||||
| Earnings Yield (Greenblatt) % | -509.28 | |||||
| FCF Yield % | -72.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Prolight Diagnostics AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.47 | ||
| Beta | 0 | ||
| Volatility % | 212.07 | ||
| 14-Day RSI | 35.05 | ||
| 14-Day ATR (kr) | 0.021115 | ||
| 20-Day SMA (kr) | 0.1404 | ||
| 12-1 Month Momentum % | -62.68 | ||
| 52-Week Range (kr) | 0.111 - 2.3 | ||
| Shares Outstanding (Mil) | 499.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Prolight Diagnostics AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Prolight Diagnostics AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Prolight Diagnostics AB Frequently Asked Questions
What is Prolight Diagnostics AB(NGM:PRLD)'s stock price today?
The current price of NGM:PRLD is kr0.12. The 52 week high of NGM:PRLD is kr2.30 and 52 week low is kr0.11.
When is next earnings date of Prolight Diagnostics AB(NGM:PRLD)?
The next earnings date of Prolight Diagnostics AB(NGM:PRLD) is 2024-08-28.
Does Prolight Diagnostics AB(NGM:PRLD) pay dividends? If so, how much?
Prolight Diagnostics AB(NGM:PRLD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers